Chinese General Practice ›› 2025, Vol. 28 ›› Issue (06): 697-704.DOI: 10.12114/j.issn.1007-9572.2023.0914
Special Issue: 内分泌代谢性疾病最新文章合辑
• Original Research • Previous Articles Next Articles
Received:
2023-12-20
Revised:
2024-04-20
Published:
2025-02-20
Online:
2024-11-25
Contact:
YUAN Xiaodan
通讯作者:
袁晓丹
作者简介:
作者贡献:
孙珍珍负责实施研究、统计分析、起草文章;崔茜、楼青青、陈晓栋、姚平负责采集数据、技术或材料支持;方丹分析/解释数据;袁晓丹设计试验、对文章的知识性内容进行批评性审阅。
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0914
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 受教育程度(高中以下)[例(%)] | 糖尿病程[M(P25,P75),月] | ||
---|---|---|---|---|---|---|---|
男性 | 女性 | ||||||
轻度及以下PA组 | 981 | 651(66.4) | 330(33.6) | 52.3±8.9 | 567(58.0) | 73.00(15.00,127.00) | |
中度PA组 | 1 389 | 885(63.7) | 504(36.3) | 51.3±10.5a | 738(53.2) | 74.00(9.00,129.00) | |
高强度PA组 | 729 | 504(69.1)b | 225(30.9)b | 48.8±10.9ab | 345(47.5)ab | 53.00(7.00,124.00) | |
检验统计量值 | 6.427 | 26.475c | 18.326 | 5.261d | |||
P值 | 0.040 | <0.001 | <0.001 | 0.072 | |||
组别 | 吸烟[例(%)] | 饮酒[例(%)] | 高血压分级[例(%)] | ||||
正常血压 | 正常高值 | 1级高血压 | 2级高血压 | 3级高血压 | |||
轻度及以下PA组 | 279(28.4) | 303(30.9) | 297(30.3) | 453(46.2) | 192(19.6) | 33(3.4) | 6(0.6) |
中度PA组 | 621(44.7)a | 636(45.8)a | 537(38.7)a | 534(38.4)a | 279(20.1) | 33(2.4)a | 6(0.4) |
高强度PA组 | 297(40.7)b | 333(45.7)a | 264(36.2)a | 333(45.7)b | 99(13.6)ab | 33(4.5)b | 0 |
检验统计量值 | 26.614 | 41.922 | 45.086 | ||||
P值 | <0.001 | <0.001 | <0.001 | ||||
组别 | DBP(mmHg) | BMI(kg/m2) | 高脂血症[例(%)] | 腰围[M(P25,P75),cm] | HbA1c(%) | SBP(mmHg) | |
轻度及以下PA组 | 76±11 | 25.8±3.3 | 276(28.1) | 91.50(86.00,97.00) | 8.80±1.95 | 127±16 | |
中度PA组 | 76±11 | 25.7±3.8 | 324(25.7)a | 90.00(84.00,96.00)a | 9.11±2.30a | 125±16a | |
高强度PA组 | 75±11 | 26.1±3.7 | 117(17.3)ab | 90.00(83.50,95.50)b | 9.38±2.24ab | 125±17 | |
检验统计量值 | 1.783c | 2.717c | 107.392 | 17.653d | 14.766c | 4.679c | |
P值 | 0.168 | 0.066 | <0.001 | <0.001 | <0.001 | 0.009 | |
组别 | TC[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | HDL-C[M(P25,P75),mmol/L] | LDL-C(mmol/L) | CIMT增厚[例(%)] | ||
轻度及以下PA组 | 4.47(3.70,5.22) | 1.73(1.16,2.60) | 0.99(0.86,1.19) | 2.58±0.83 | 372(37.9) | ||
中度PA组 | 4.52(3.79,5.19) | 1.69(1.14,2.66) | 1.00(0.85,1.18) | 2.71±0.88a | 438(31.5)a | ||
高强度PA组 | 4.40(3.82,5.14) | 1.70(1.21,2.46) | 1.00(0.86,1.23) | 2.82±0.95ab | 258(35.4) | ||
检验统计量值 | 1.199d | 0.517d | 0.838d | 15.358c | 10.748 | ||
P值 | 0.549 | 0.772 | 0.658 | <0.001 | 0.005 |
Table 1 Comparison of baseline data for T2DM patients with different levels of PA
组别 | 例数 | 性别[例(%)] | 年龄(岁) | 受教育程度(高中以下)[例(%)] | 糖尿病程[M(P25,P75),月] | ||
---|---|---|---|---|---|---|---|
男性 | 女性 | ||||||
轻度及以下PA组 | 981 | 651(66.4) | 330(33.6) | 52.3±8.9 | 567(58.0) | 73.00(15.00,127.00) | |
中度PA组 | 1 389 | 885(63.7) | 504(36.3) | 51.3±10.5a | 738(53.2) | 74.00(9.00,129.00) | |
高强度PA组 | 729 | 504(69.1)b | 225(30.9)b | 48.8±10.9ab | 345(47.5)ab | 53.00(7.00,124.00) | |
检验统计量值 | 6.427 | 26.475c | 18.326 | 5.261d | |||
P值 | 0.040 | <0.001 | <0.001 | 0.072 | |||
组别 | 吸烟[例(%)] | 饮酒[例(%)] | 高血压分级[例(%)] | ||||
正常血压 | 正常高值 | 1级高血压 | 2级高血压 | 3级高血压 | |||
轻度及以下PA组 | 279(28.4) | 303(30.9) | 297(30.3) | 453(46.2) | 192(19.6) | 33(3.4) | 6(0.6) |
中度PA组 | 621(44.7)a | 636(45.8)a | 537(38.7)a | 534(38.4)a | 279(20.1) | 33(2.4)a | 6(0.4) |
高强度PA组 | 297(40.7)b | 333(45.7)a | 264(36.2)a | 333(45.7)b | 99(13.6)ab | 33(4.5)b | 0 |
检验统计量值 | 26.614 | 41.922 | 45.086 | ||||
P值 | <0.001 | <0.001 | <0.001 | ||||
组别 | DBP(mmHg) | BMI(kg/m2) | 高脂血症[例(%)] | 腰围[M(P25,P75),cm] | HbA1c(%) | SBP(mmHg) | |
轻度及以下PA组 | 76±11 | 25.8±3.3 | 276(28.1) | 91.50(86.00,97.00) | 8.80±1.95 | 127±16 | |
中度PA组 | 76±11 | 25.7±3.8 | 324(25.7)a | 90.00(84.00,96.00)a | 9.11±2.30a | 125±16a | |
高强度PA组 | 75±11 | 26.1±3.7 | 117(17.3)ab | 90.00(83.50,95.50)b | 9.38±2.24ab | 125±17 | |
检验统计量值 | 1.783c | 2.717c | 107.392 | 17.653d | 14.766c | 4.679c | |
P值 | 0.168 | 0.066 | <0.001 | <0.001 | <0.001 | 0.009 | |
组别 | TC[M(P25,P75),mmol/L] | TG[M(P25,P75),mmol/L] | HDL-C[M(P25,P75),mmol/L] | LDL-C(mmol/L) | CIMT增厚[例(%)] | ||
轻度及以下PA组 | 4.47(3.70,5.22) | 1.73(1.16,2.60) | 0.99(0.86,1.19) | 2.58±0.83 | 372(37.9) | ||
中度PA组 | 4.52(3.79,5.19) | 1.69(1.14,2.66) | 1.00(0.85,1.18) | 2.71±0.88a | 438(31.5)a | ||
高强度PA组 | 4.40(3.82,5.14) | 1.70(1.21,2.46) | 1.00(0.86,1.23) | 2.82±0.95ab | 258(35.4) | ||
检验统计量值 | 1.199d | 0.517d | 0.838d | 15.358c | 10.748 | ||
P值 | 0.549 | 0.772 | 0.658 | <0.001 | 0.005 |
项目 | 例数 | PA | CIMT增厚率 | ||
---|---|---|---|---|---|
轻度及以下PA组 | 中度PA组 | 高强度PA组 | |||
性别 | |||||
男 | 2 040 | 651(31.9) | 885(43.4) | 504(24.7) | 711(34.9) |
女 | 1 059 | 330(31.2) | 504(47.6) | 225(21.2) | 357(33.7) |
χ2值 | 6.427 | 0.402 | |||
P值 | 0.040 | 0.526 | |||
年龄 | |||||
青年 | 723 | 168(23.2) | 315(43.6) | 240(33.2) | 144(19.9) |
中年 | 1 818 | 618(34.0) | 801(44.1) | 399(21.9) | 699(38.4)a |
老年 | 558 | 195(34.9) | 273(48.9) | 90(16.2) | 225(40.3)a |
χ2值 | 67.461 | 89.001 | |||
P值 | <0.001 | <0.001 |
Table 2 Comparison of PA level and thickening rate of CIMT in T2DM patients with different gender and age
项目 | 例数 | PA | CIMT增厚率 | ||
---|---|---|---|---|---|
轻度及以下PA组 | 中度PA组 | 高强度PA组 | |||
性别 | |||||
男 | 2 040 | 651(31.9) | 885(43.4) | 504(24.7) | 711(34.9) |
女 | 1 059 | 330(31.2) | 504(47.6) | 225(21.2) | 357(33.7) |
χ2值 | 6.427 | 0.402 | |||
P值 | 0.040 | 0.526 | |||
年龄 | |||||
青年 | 723 | 168(23.2) | 315(43.6) | 240(33.2) | 144(19.9) |
中年 | 1 818 | 618(34.0) | 801(44.1) | 399(21.9) | 699(38.4)a |
老年 | 558 | 195(34.9) | 273(48.9) | 90(16.2) | 225(40.3)a |
χ2值 | 67.461 | 89.001 | |||
P值 | <0.001 | <0.001 |
变量 | 赋值 |
---|---|
性别 | 男=1,女=2 |
年龄 | 实测值 |
受教育程度 | 高中以下=0,高中及高中以上=1 |
吸烟 | 否=0,是=1 |
饮酒 | 否=0,是=1 |
糖尿病病程 | 实测值 |
高血压分级 | 正常血压=1,正常高值=2,1级高血压=3,2级高血压=4,3级高血压=5 |
BMI | 实测值 |
HbA1c | 实测值 |
TG | 实测值 |
HDL-C | 实测值 |
LDL-C | 实测值 |
CIMT增厚 | 否=0,是=1 |
Table 3 An assignment table for binary logistic regression analysis of the effect of different PA levels on CIMT
变量 | 赋值 |
---|---|
性别 | 男=1,女=2 |
年龄 | 实测值 |
受教育程度 | 高中以下=0,高中及高中以上=1 |
吸烟 | 否=0,是=1 |
饮酒 | 否=0,是=1 |
糖尿病病程 | 实测值 |
高血压分级 | 正常血压=1,正常高值=2,1级高血压=3,2级高血压=4,3级高血压=5 |
BMI | 实测值 |
HbA1c | 实测值 |
TG | 实测值 |
HDL-C | 实测值 |
LDL-C | 实测值 |
CIMT增厚 | 否=0,是=1 |
组别 | 模型1 | 模型2 | 模型3 | |||
---|---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
中度PA | 0.754(0.635~0.895) | 0.001 | 0.813(0.662~0.997) | 0.047 | 0.775(0.629~0.956) | 0.017 |
高强度PA | 0.897(0.745~1.094) | 0.284 | 1.068(0.847~1.346) | 0.581 | 1.036(0.817~1.313) | 0.773 |
Table 4 Binary Logistic regression analysis of the effect of different PA levels on CIMT
组别 | 模型1 | 模型2 | 模型3 | |||
---|---|---|---|---|---|---|
OR(95%CI) | P值 | OR(95%CI) | P值 | OR(95%CI) | P值 | |
中度PA | 0.754(0.635~0.895) | 0.001 | 0.813(0.662~0.997) | 0.047 | 0.775(0.629~0.956) | 0.017 |
高强度PA | 0.897(0.745~1.094) | 0.284 | 1.068(0.847~1.346) | 0.581 | 1.036(0.817~1.313) | 0.773 |
[1] |
|
[2] |
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志,2021,37(4):311-398. DOI:10.3760/cma.j.cn311282-20210304-00142.
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
中华人民共和国卫生部. 冠状动脉粥样硬化性心脏病诊断标准:WS 319-2010[S]. 2010.
|
[10] |
|
[11] |
|
[12] |
中国高血压防治指南修订委员会. 中国高血压防治指南2010[J]. 中华心血管病杂志,2011,39(7):579-616. DOI:10.3760/cma.j.issn.0253-3758.2011.07.002.
|
[13] |
中国成人血脂异常防治指南修订联合委员会. 中国成人血脂异常防治指南(2016年修订版)[J]. 中华全科医师杂志,2017,16(1):15-35. DOI:10.3760/cma.j.issn.1671-7368.2017.01.006.
|
[14] |
|
[15] |
王美凤,裴丽,张清. 三种体力活动量表在2型糖尿病患者中应用的信效度检验[J]. 中国康复医学杂志,2016,31(9):945-949. DOI:10.3969/j.issn.1001-1242.2016.09.003.
|
[16] |
樊萌语,吕筠,何平平. 国际体力活动问卷中体力活动水平的计算方法[J]. 中华流行病学杂志,2014,35(8):961-964. DOI:10.3760/cma.j.issn.0254-6450.2014.08.019.
|
[17] | |
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[1] | ZHANG Qiang, TANG Min, GUANG Yajie, LIU Dan, ZHAO Xueyan, ZHAO Yuanyuan, ZHANG Lin, NUERBAHETI. Analysis of the Current Status of Atrial Fibrillation Epidemiological Survey in Shihezi Area of Xinjiang Corps [J]. Chinese General Practice, 2024, 27(33): 4162-4167. |
[2] | WU Qingyue, CHEN Xiaoling, ZHOU Xunqiong, YANG Jingyuan, ZHOU Quanxiang, YANG Xing. Study on the Relationship between Inter-arm Blood Pressure Difference and Mild Cognitive Impairment in Rural Elderly People [J]. Chinese General Practice, 2024, 27(29): 3616-3622. |
[3] | LIU Xin, WEI Yanan, LIU Jie, WANG Jingtong. Research of Influencing Factors for Physical Impairment Combined with Cognitive Impairment in the Elderly [J]. Chinese General Practice, 2024, 27(26): 3281-3288. |
[4] | TU Shuting, LIN Jiaying, ZHUANG Jinyang, XIANG Jingnan, WEI Dongshuai, XIE Yong, JIA Jie. Incidence and Related Factors of Post-stroke Cognitive Impairment: a Multicenter Cross-sectional Study Based on Full-cycle Rehabilitation in Stroke [J]. Chinese General Practice, 2024, 27(23): 2829-2837. |
[5] | LI Mingzhe, TIAN Yichuan, WANG Chenglong, WANG Jingjing. Study on the Independent and Joint Effects of Physical Activity and Sleep on Low Back Pain in Middle-aged and Elderly Adults [J]. Chinese General Practice, 2024, 27(23): 2869-2874. |
[6] | ZHAO Zezhou, WANG Jieping, DU Xueping, WU Wei, YAN Wei, LI Qian, GUAN Yajie. Study on the Status of Consultations in General Medicine Departments in Tertiary Care Hospitals [J]. Chinese General Practice, 2024, 27(19): 2319-2323. |
[7] | WU Meiqian, XIAO Jin, LI Feifei, HU Rongrong, LIU Caixia. 24-hour Movement Behaviors: a New Direction for the Study of Factors Affecting Health of the Elderly [J]. Chinese General Practice, 2024, 27(15): 1911-1916. |
[8] | CHENG Jingwei, QIAO Junjun, YIN Zhen, HU Junpeng, WANG Qinghe, LIU Yangqing, WANG Yanfang. Interpretation of ISPAD Clinical Practice Consensus Guidelines 2022: Exercise in Children and Adolescents with Diabetes [J]. Chinese General Practice, 2023, 26(30): 3719-3724. |
[9] | LI Liqiang, WU Jin, ZHANG Liqiang, WANG Xiaozan. Australian Physical Activity Referral and Its Implications for the Sharing Mechanism of General Practice and Sports Co-treatment in China [J]. Chinese General Practice, 2023, 26(19): 2311-2317. |
[10] | FU Shi, CHEN Chen, YU Mengzhu, JIN Changqin, HE Gan, CHU Qiao, HE Yaping. Potential Effect of Walking on Emotional Health among Breast Cancer Survivors: the Mediating Effects of Different Dimensions of Posttraumatic Growth [J]. Chinese General Practice, 2023, 26(17): 2089-2094. |
[11] | China Gerontological Nursing Alliance, Xiang Ya Nursing School (Xiangya Oceanwide Health Management Research Institute of Central South University), Xiangya Hospital Central South University (National Clinical Research Center for Geriatric Disorders), Beijing Hospital (National Center for Gerontology, National Clinical Research Center for Geriatric Disorders), ZENG Xianmei, HU Mingyue, FENG Hui. Clinical Practice Guideline on Non-pharmacological Interventions for Older Adults with Cognitive Dysfunction: Physical Activity [J]. Chinese General Practice, 2023, 26(16): 1927-1937. |
[12] | CHEN Runlin, HE Tufeng, TAO Lijun, QIN Lingqiao, ZHANG Dacheng, ZHANG Yifan, ZHAO Min, ZHONG Qiuan. Effects of Cardiovascular Risk Factors on the Progression of Carotid Intima-media Thickening [J]. Chinese General Practice, 2023, 26(14): 1709-1715. |
[13] | YANG Changyuan, LING Xitao, HU Xiaoxuan, ZHANG La, QIN Xindong, LIU Hui, LU Fuhua, SU Guobin. Clinical Interpretation of Physical Activity and Exercise in Peritoneal Dialysis: International Society for Peritoneal Dialysis and the Global Renal Exercise Network Practice Recommendations [J]. Chinese General Practice, 2023, 26(09): 1031-1037. |
[14] | CHEN Panpan, YU Hongjun, QIU Jun. Harvard Alumni Health Study Physical Activity Questionnaire for Chinese College Students: a Cross-validation Study [J]. Chinese General Practice, 2023, 26(08): 1015-1021. |
[15] | ZHAO Kang, ZHU Hanfei, XU Ting, MIAO Xueyi, JIANG Xiaoman, XU Qin. Dietary and Physical Activity Behavior Promotion Strategies after Bariatric Surgery from a Cognitive Perspective: an Integrative Review [J]. Chinese General Practice, 2023, 26(07): 790-799. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||